Sean Sinden

A call for community engagement: Exploring the harms and benefits of molecular HIV surveillance

“The first letter in HIV stands for Human,” writes Dr. Alexander McClelland in a co-authored...

Communities teaching communities: A framework for Indigenous community development

With community partners across Alberta and Saskatchewan, the DRUM & SASH team is building a knowledge base to support Indigenous capacity strengthening

Putting data into action: How CTN researchers track, prevent, and manage HIV in infants

The Canadian Pediatric and Perinatal HIV/AIDS Research Group is a collection of clinicians and researchers that form the primary resource for pediatric HIV in Canada

Everyone ages differently: Cardiovascular disease and HIV

The CTN’s HIV and Aging Cohort Study aims to understand how HIV can affect the development of heart disease, and what can be done to address it

Age, altruism, or a long-term view: Why do people living with HIV get the COVID-19 vaccine?

Understanding COVID-19 vaccine confidence in people living with HIV in Canada

CTN study tests new drug for the first time in people living with HIV

The drug works against CMV, a common virus that may be a main cause of inflammation and health problems in people living with HIV

Call for nominations now open for CTN C4 Teams Community Co-Lead

New research comparing HIV medications set to change international recommendations

The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV

Here’s what we know about COVID-19 & HIV

Many questions remain about COVID-19 and what it means for people living with HIV. We explore the research so far